Coverage and Reimbursement
CPT codes for Cardiac Device Monitoring
Effective January 1, 2009, CPT® codes have been established for cardiac device monitoring, including codes that apply to the review of physiologic data from OptiVol® Fluid Status Monitoring and the Cardiac Compass® Report.1
- The CPT codes related to OptiVol are for device interrogations of physiologic (rather than rhythm) data, and not for programming. An interrogation includes physician analysis, review, and report.
Coverage and payment is contingent upon service delivery that is medically reasonable and necessary. Payers, such as Medicare, may have specific diagnostic test supervision requirements, coverage requirements, coding edits, and other requirements that may apply to the use of these new codes. The reimbursement reflects national Medicare MpFS rates. The reimbursement may vary according to payer requirements. Please contact your local payer(s) for interpretation of the appropriate codes to use for specific procedures. The ultimate responsibility for correct coding lies with the provider of services.
- Implantable cardiac monitor (ICM) interrogations can be performed using the CardioSight® Reader or CareLink® programmer, or remotely using the Medtronic CareLink Network.
For more information about coverage of and reimbursement for OptiVol reports, please visit www.medtronic.com
- CPT copyright 2009 American Medical Association. All rights reserved. CPT is a registered trademark of the American Medical Association. All rights reserved. CPT is a registered trademark of the American Medical Association. Applicable FARS/DFARS Restriction Apply to Government Use. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly practice medicine or dispense medical services. The AMA assumes no liability for the data contained or not contained herein.
OptiVol and Medtronic Diagnostic Reports Can Be Obtained In Three Ways:
CMS to Track Heart Failure Readmissions
Effective October 1, 2009, CMS will track heart failure readmissions within 30 days of discharge.
As hospitals partner with physicians to reduce rehospitalizations, OptiVol Fluid Status Monitoring may be a clinically useful tool in the management of their heart failure patients.
All patient data and clinic data displayed on the screens is fictitious and for demonstration purposes.